Salarius Pharmaceuticals Inc [NASDAQ: SLRX] gained 134.50% or 2.1 points to close at $3.67 with a heavy trading volume of 120002980 shares.
The daily chart for SLRX points out that the company has recorded 85.35% gains over the past six months.
If we look at the average trading volume of 346.99K shares, SLRX reached to a volume of 120002980 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Salarius Pharmaceuticals Inc [SLRX]:
Ladenburg Thalmann have made an estimate for Salarius Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 27, 2020.
The Average True Range (ATR) for Salarius Pharmaceuticals Inc is set at 0.55 The Price to Book ratio for the last quarter was 1.81, with the Price to Cash per share for the same quarter was set at 2.27.
Trading performance analysis for SLRX stock
Salarius Pharmaceuticals Inc [SLRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 115.88. With this latest performance, SLRX shares gained by 126.54% in over the last four-week period, additionally plugging by 85.35% over the last 6 months – not to mention a drop of -30.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLRX stock in for the last two-week period is set at 81.78, with the RSI for the last a single of trading hit 85.83, and the three-weeks RSI is set at 77.97 for Salarius Pharmaceuticals Inc [SLRX]. The present Moving Average for the last 50 days of trading for this stock 1.5500, while it was recorded at 2.0800 for the last single week of trading, and 2.3900 for the last 200 days.
Salarius Pharmaceuticals Inc [SLRX]: A deeper dive into fundamental analysis
Salarius Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.09 and a Current Ratio set at 4.09.
An analysis of Institutional ownership at Salarius Pharmaceuticals Inc [SLRX]
There are presently around $0.36%, or 0.37%% of SLRX stock, in the hands of institutional investors.
